Take-Home Naloxone for Subjects with Opioid Addictio
Not Applicable
- Conditions
- F11.2
- Registration Number
- DRKS00023600
- Lead Sponsor
- Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität am Bezirksklinikum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 537
Inclusion Criteria
ICD 10 F11.2 or F19.2 (main drug opioids)
Exclusion Criteria
- urgent need for psychiatric or somatic treatment
- no voluntary participation
- missing informed consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survey how overdose emergencies were dealt with by trained participants, incl. use of Take-Home Naloxone (semi-structured interview, continuously while in contact with participants)
- Secondary Outcome Measures
Name Time Method - Knowledge on dealing with overdose emergencies, incl. Take-Home Naloxone (questionnaire before and after drug emergency training for all participants; catamnestic questionnaire at least 3 months after training for a random sample of trained participants)<br><br>- Elaboration of best-practice models for the implementation of drug emergency trainings, incl. Take-Home Naloxone (structured survey of experiences among training providers, participants and cooperating institutions, e.g. emergency services; at the end of the project)